Global trends for drug-device combination product regulation are moving toward an integrated approach, shifting away from quality systems that prioritise just one component of the combination. From integrated quality sy...

Latest issue now available. Join thousands of subscribers who have discovered the convenience of our free monthly publication, by signing up today https://ow.ly/Hxx750Zi8bm. Compiled and collated by ICON’s Regulatory ...

Join ICON Biotech at CTO East Coast 2026, taking place 30 June – 1 July at the Boston Marriott Burlington, MA. Meet our team at Booth \#18 to learn how our specialised clinical development services support biotech progra...

Recent regulatory shifts have critical implications for how biosimilar developers generate and prioritise information. Read ICON’s latest article in PharmTech Magazine, to learn what these changes mean for data collect...

Modern biologics manufacturing demands regulatory strategies that keep pace with evolving modalities, data driven controls and continuous processing. This article outlines practical considerations for aligning viral saf...

Since 2024, new guidance from the FDA and EMA has advanced efforts to streamline biosimilar development to enhance commercial appeal for developers. Explore the implications of new regulatory guidance and publications,...

We’re proud to be sponsoring the SOLAR conference taking place on June 25-27. Our hepatology team will be there and looking forward to connecting with others working to advance liver disease research, especially across ...

Latest issue out now. Do you struggle to keep on top of regulatory changes affecting the world of medicine and medical device clinical trials? Join thousands of subscribers who have discovered the convenience of our fr...

More than a decade ago, Yordan Zahariev joined ICON as a Clinical Trial Assistant. Today, he leads one of ICON's largest CTA teams in Bulgaria as a Clinical Operations Manager. In our latest career story, Yordan reflect...

Attending CTO East Coast in Boston? Join Padma Varadharajan on 30 June at 9:30am for her core session entitled: “Practical considerations for navigating the landscape of global oncology trials in 2026 and beyond.” This ...

ICON is proud to sponsor the SOLAR conference. Our hepatology specialists will be on-site (25-27 June), talking with peers about the practical side of running liver disease trials from AI-driven site selection to imagi...

Last week, we proudly celebrated a significant milestone, 30 years of ICON Germany. Over the past three decades, our teams in Germany have played an important role in advancing clinical research and supporting customer...